Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability
F Qi, J Wu, Q Fan, F He, G Tian, T Yang, G Ma… - Colloids and surfaces B …, 2013 - Elsevier
Exenatide-loaded poly (d, l-lactic-co-glycolic acid)(PLGA) microspheres hold great potential
as a drug delivery system to treat type 2 diabetes mellitus (T2DM) because they can …
as a drug delivery system to treat type 2 diabetes mellitus (T2DM) because they can …
Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: Development, pharmacokinetics, biodistribution and pharmacodynamics
G Sharma, CF Van Der Walle, MNVR Kumar - International journal of …, 2013 - Elsevier
The in vitro/in vivo characterization of antacid-insulin co-encapsulated poly (lactide-co-
glycolide)(PLGA) nanoparticles is presented here. The optimized nanoparticle composition …
glycolide)(PLGA) nanoparticles is presented here. The optimized nanoparticle composition …
Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process
AZ Chen, YM Yang, SB Wang, GY Wang… - Journal of Materials …, 2013 - Springer
Abstract A high-voltage (10 kV) electrostatic antisolvent process was used to prepare
methotrexate (MTX)-loaded, large, highly-porous poly-l-lactide (PLLA) microspheres. MTX …
methotrexate (MTX)-loaded, large, highly-porous poly-l-lactide (PLLA) microspheres. MTX …
Evaluation of poly (1, 6-bis-(p-carboxyphenoxy) hexane-co-sebacic acid microspheres for controlled basal insulin delivery
C Manoharan, J Singh - Pharmaceutical research, 2013 - Springer
Abstract Purpose To develop poly 1, 3-bis-(p-carboxyphenoxy) hexane-co-sebacic acid (p
(CPH/SA)) microspheres for controlled basal insulin delivery and evaluate their in vivo …
(CPH/SA)) microspheres for controlled basal insulin delivery and evaluate their in vivo …
Differential permeation of piroxicam-loaded PLGA micro/nanoparticles and their in vitro enhancement
Piroxicam is a non-steroidal anti-inflammatory drug used for the treatment of
musculoskeletal pain. The main problem encountered when piroxicam is administered orally …
musculoskeletal pain. The main problem encountered when piroxicam is administered orally …